CGEN FY 2025 Earnings — Compugen Ltd. Revenue & Financial Results | Market Cap Arena

CGENCompugen Ltd.

$202M

FY 2025 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$73M+161.1% YoY

Gross Profit

$64M87.3% margin

Operating Income

$31M43.1% margin

Net Income

$35M48.6% margin

EPS (Diluted)

$0.38

Cash Flow

Operating Cash Flow

$32M

Free Cash Flow

$31M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$157M

Total Liabilities

$54M

Stockholders' Equity

$103M

Cash & Equivalents

$91M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$73M	$28M	+161.1%
Gross Profit	$64M	$20M	+218.6%
Operating Income	$31M	-$15M	+310.4%
Net Income	$35M	-$14M	+348.4%